+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
Healthy Volunteers
ID06515587

Study of Lewis Antigen and CA19-9 Tests to Predict Prognosis in Pancreatic Cancer Patients

Led by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Updated on 2025-05-14

40

Participants Needed

1

Research Sites

17 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating how the combination of Lewis antigen and CA19-9 blood tests can help predict the prognosis of patients with pancreatic ductal adenocarcinoma PDAC. This study is prospective and involves multiple centers, aiming to classify pancreatic cancer patients by their Lewis antigen status and observe how this relates to their survival. The study also includes people without pancreatic cancer to evaluate the distribution of Lewis antigen types and the tests specificity. Participants will undergo one Lewis genotype test and at least one CA19-9 test. These tests help identify different subtypes of pancreatic cancer to assess malignancy and survival outcomes. The study will look at how age, Lewis antigen subtype, and overall survival relate to prognosis. Both pancreatic cancer patients and non-pancreatic cancer subjects will be enrolled for comparison. During the study, participants will have blood samples collected for Lewis antigen and CA19-9 testing, followed by regular follow-ups to monitor survival up to 12 months after treatment. Researchers will measure how well the combined testing predicts pancreatic cancer prognosis. Participants will be monitored for any additional health issues, and the study will last until October 2026, starting in August 2024.

CONDITIONS

Brief Title

Clinical Study of Lewis Antigen Assay Combined With CA19-9 Assay to Assess Prognosis in Patients With Pancreatic Cancer

Research Team

L

Long Jiang, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here